Trial Profile
Heating effect of miriplatin on transcatheter arterial chemoembolization therapy for hepatocellular carcinoma: a randomized controlled trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2018
Price :
$35
*
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 21 Jun 2018 Status changed from recruiting to discontinued.
- 02 May 2013 New trial record